they are starting again with TGA because they feel it should be registered in OSLs home country.
TGA can be a great preparatory and (often) bellweather process to preceed FDA submission, but it costs time, focus and $$. Registering in any jurisdiction should have a robust business case. 'Feeling' a product should be registered in your 'home country' is a poor justification for the use of sh funds, imo.
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil onboards first patient in PANCOSIL Clinical Trial
Ann: OncoSil onboards first patient in PANCOSIL Clinical Trial, page-19
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.002(15.4%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $368.9K | 36.70M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 2295654 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 6892565 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2098505 | 0.010 |
29 | 8258886 | 0.009 |
14 | 8739668 | 0.008 |
6 | 2051558 | 0.007 |
7 | 4255000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 6892565 | 14 |
0.012 | 7021057 | 10 |
0.013 | 7199900 | 4 |
0.014 | 2990241 | 7 |
0.015 | 2107000 | 9 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |